High-throughput brain organoid platform for drug screening and disease research
Official title: High-throughput Organoid Platform for Electrophysiology Studies (HOPES)
Funded at Cfd Research Corporation · NIH-11408054 · Data updated 2026-11-12
A new, automated platform will grow and test hundreds of brain organoids to study Alzheimer's disease and related conditions.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cfd Research Corporation NIH-funded |
| Lab location | 1 site (Huntsville, United States) |
| Project start | August 17, 2026 |
| Project end | August 16, 2027 |
| Funding year | 2026 |
| Award (this year) | $349,752 |
| NIH project number | 1R41TR006349-01 |
| Project ID | NIH-11408054 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are individuals with or at risk for Alzheimer’s-related cognitive changes whose data or samples contribute to understanding disease mechanisms; patients may benefit indirectly through faster therapeutic development.
✕Less likely to help
Patients without access to participating centers or those not involved in brain organoid research may not directly benefit.
What this research studies
This project aims to create a scalable, automated system that grows brain organoids, measures their electrical activity, and screens how potential drugs or environmental factors affect them. It uses a high-density, low-noise multi-well sensor array embedded in a microphysiological system to monitor organoid maturation and function. The goal is to provide a more human-relevant model for studying Alzheimer’s disease and environmental risks, with an emphasis on throughput and data quality. If successful, researchers could use the platform to identify promising therapies and better understand disease mechanisms.
Why it matters
Potential benefit: It could accelerate discovery of treatments and a deeper understanding of Alzheimer’s biology by using human brain organoids.
How similar studies have gone: Other organoid platforms have shown promise, but high-throughput, integrated electrophysiology in a vascularized 3D system remains an emerging area.
Where this research is happening
-
Cfd Research Corporation
Huntsville, United States Active
Researchers
- Principal investigator: Roehm, Kevin — Cfd Research Corporation
- Study coordinator: Roehm, Kevin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.